1427364: RIZATRIPTAN BENZOATE TABLETS.
The RIZATRIPTAN BENZOATE TABLETS is a the manufacturer industrial component. Key specifications include part_name_assigned_by_controlling_agency: MAXALT (RIZATRIPTAN) TABLETS, 10 MG, 18S. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-659-2917, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| part_name_assigned_by_controlling_agency | MAXALT (RIZATRIPTAN) TABLETS, 10 MG, 18S |
| NSN | 6505-01-659-2917 |
| SPECIAL FEATURES | RIZATRIPTAN BENZOATE 10MG TABLETS; INDICATED FOR THE ACUTE TREATMENT OF MIGRAINE WITH OR WITHOUT AURA IN ADULTS AND IN PEDIATRIC PATIENTS 6 TO 17 YEARS OLD; EACH TABLET CONTAINS 14.53 MG OF RIZATRIPTAN BENZOATE, EQUIVALENT TO 10 MG RIZATRIPTAN; SUPPLIED IN A BOX CONTAINING 18 UNIT-DOSE TABLETS; STRENGTH: 10 MG; STORE AT ROOM TEMPERATURE, 59-86 F (15-30 C). |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | MAXALT (RIZATRIPTAN) TABLETS, 10 MG, 18S |